NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Total Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Assets | ₹213 Cr | ₹163 Cr | ₹173 Cr | ₹125 Cr | ₹81 Cr |
What is the latest Total Current Assets ratio of NGL FINECHEM ?
Year | Total Current Assets |
---|---|
Mar2024 | ₹213 Cr |
Mar2023 | ₹163 Cr |
Mar2022 | ₹173 Cr |
Mar2021 | ₹125 Cr |
Mar2020 | ₹81 Cr |
How is Total Current Assets of NGL FINECHEM Trending?
Years | Total Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹213 Cr | 30.75 | |
Mar2023 | ₹163 Cr | -6.25 | |
Mar2022 | ₹173 Cr | 39.32 | |
Mar2021 | ₹125 Cr | 54.00 | |
Mar2020 | ₹81 Cr | - |
Compare Total Current Assets of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹699.3 Cr | 1.6% | 1.9% | -53.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 1.6% |
1.9% |
-53.4% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses